France
University of Montpellier - Virulence bactérienne et infections chroniques (VBIC)
SARS-CoV-2, COVID-19 vaccine, Immunological efficacy, Randomized trial, Heterologous vaccination, mRNA vaccine, BNT162b2 vaccine, mRNA-1273 vaccine.